Advertisement

Topics

TranS1 Company Profile

16:42 EST 10th December 2018 | BioPortfolio

TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. AxiaLIF achieves a faster recovery time, cost savings, and lower incidence of complication compared to alternative procedures.


News Articles [1 Associated News Articles listed on BioPortfolio]

Scientia Vascular Appoints Rick Randall to Its Board

Scientia Vascular, LLC, a commercial-stage medical device company with patented, proprietary, and FDA-approved vascular access technology, recently appointed Rick Randall as execu...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

TranS1

TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally inv...

More Information about "TranS1" on BioPortfolio

We have published hundreds of TranS1 news stories on BioPortfolio along with dozens of TranS1 Clinical Trials and PubMed Articles about TranS1 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TranS1 Companies in our database. You can also find out about relevant TranS1 Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record